{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:44:48Z","timestamp":1791611088524,"version":"4.3.4"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GI1008C"],"award-info":[{"award-number":["01GI1008C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.neurobiolaging.2021.08.020","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T11:49:54Z","timestamp":1630928994000},"page":"31-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease"],"prefix":"10.1016","volume":"109","author":[{"given":"Daniel","family":"Chariss\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6633-4861","authenticated-orcid":false,"given":"Guray","family":"Erus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Pomponio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gorges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Liepelt-Scarfone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1721-502X","authenticated-orcid":false,"given":"Oliver","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9730-9228","authenticated-orcid":false,"given":"Kathrin","family":"Reetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8903-0593","authenticated-orcid":false,"given":"J\u00f6rg B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Storch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dodel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Kalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7106-9270","authenticated-orcid":false,"given":"Jan","family":"Kassubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Hilker-Roggendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Baudrexel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0001","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/WNL.56.6.730","article-title":"Risk of dementia in Parkinson's disease: a community-based, prospective study","volume":"56","author":"Aarsland","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","article-title":"Cognitive decline in Parkinson disease","volume":"13","author":"Aarsland","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2006.06.005","article-title":"The correlative triad among aging, dopamine, and cognition: current status and future prospects","volume":"30","author":"B\u00e4ckman","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"issue":"3-4","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0004","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000331490","article-title":"Parkinson's disease and dementia: a longitudinal study (DEMPARK)","volume":"37","author":"Balzer-Geldsetzer","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0005","doi-asserted-by":"crossref","first-page":"618","DOI":"10.14336\/AD.2019.0617","article-title":"T1-weighted MRI-driven brain age estimation in Alzheimer's disease and Parkinson's disease","volume":"11","author":"Beheshti","year":"2020","journal-title":"Aging Dis"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.102063","article-title":"Bias-adjustment in neuroimaging-based brain age frameworks: A robust scheme","volume":"24","author":"Beheshti","year":"2019","journal-title":"NeuroImage Clin"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0007","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0008","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mds.25844","article-title":"Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease","volume":"29","author":"Berg","year":"2014","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0009","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","article-title":"Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects","volume":"72","author":"Bohnen","year":"2015","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.60.12.1745","article-title":"Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study","volume":"60","author":"Bohnen","year":"2003","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0011","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00415-005-0971-0","article-title":"Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia","volume":"253","author":"Bohnen","year":"2006","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0012","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actpsy.2007.09.008","article-title":"Working memory and inhibition across the adult life-span","volume":"128","author":"Borella","year":"2008","journal-title":"Acta psychologica"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2004.09.006","article-title":"Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate","volume":"44","author":"Buckner","year":"2004","journal-title":"Neuron"},{"issue":"21","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0014","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0015","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0016","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/B978-0-12-804766-8.00010-8","article-title":"Neuropsychology of aging","volume":"167","author":"Cohen","year":"2019","journal-title":"Handbook Clin Neurol"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0017","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.tins.2017.10.001","article-title":"Predicting age using neuroimaging: innovative brain ageing biomarkers","volume":"40","author":"Cole","year":"2017","journal-title":"Trends Neurosci"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0018","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/mds.27037","article-title":"Aging and Parkinson\u2019s disease: different sides of the same coin?","volume":"32","author":"Collier","year":"2017","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0019","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.parkreldis.2012.04.028","article-title":"Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia","volume":"18","author":"Compta","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 5","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0020","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain J Neurol"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0021","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.parkreldis.2013.03.009","article-title":"Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study","volume":"19","author":"Compta","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0022","article-title":"Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers","volume":"4","author":"Da","year":"2013","journal-title":"NeuroImage Clin"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0023","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neurobiolaging.2006.11.010","article-title":"Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging","volume":"29","author":"Davatzikos","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"Pt 8","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0024","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1093\/brain\/awp091","article-title":"Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index","volume":"132","author":"Davatzikos","year":"2009","journal-title":"Brain J Neurol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cercor\/bhn113","article-title":"The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals","volume":"19","author":"Dickerson","year":"2009","journal-title":"Cereb Cortex (New York, N.Y. 1991)"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0026","series-title":"Analysis of longitudinal data","author":"Diggle","year":"2009"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0027","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/jnp.12028","article-title":"Executive dysfunction in Parkinson's disease: a review","volume":"7","author":"Dirnberger","year":"2013","journal-title":"J Neuropsychology"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.acra.2013.09.010","article-title":"Multi-atlas skull-stripping","volume":"20","author":"Doshi","year":"2013","journal-title":"Acad Radiol"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0029","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroimage.2015.11.073","article-title":"MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection","volume":"127","author":"Doshi","year":"2016","journal-title":"NeuroImage"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0030","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1212\/01.wnl.0000341769.50075.bb","article-title":"Incidence and remaining lifetime risk of Parkinson disease in advanced age","volume":"72","author":"Driver","year":"2009","journal-title":"Neurology"},{"issue":"29","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0031","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1002\/sim.3429","article-title":"An R2 statistic for fixed effects in the linear mixed model","volume":"27","author":"Edwards","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0032","unstructured":"Eickhoff C, Hoffstaedter F, Casper J, Reetz K, Mathys C, Dogan I, Amunts K, Schnitzler A, Eickhoff S. Brain aging in Parkinson's disease related to disease duration, cognitive and motor impairment; In: DGN-Kongress 2020 \u2013 Abstracts. Abstract Number 633; URN: urn:nbn:de:101:1-2020110317121833688422"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0033","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0034","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0035","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1523\/JNEUROSCI.3785-09.2010","article-title":"CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. The Journal of neuroscience the official journal of the Society for","volume":"30","author":"Fjell","year":"2010","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0036","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1024\/1662-9647\/a000074","article-title":"Longitudinal changes in individual brainage in healthy aging, mild cognitive impairment, and Alzheimer's disease","volume":"25","author":"Franke","year":"2012","journal-title":"GeroPsych"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0037","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3389\/fneur.2019.00789","article-title":"Ten years of brainage as a neuroimaging biomarker of brain aging: what insights have we gained?","volume":"10","author":"Franke","year":"2019","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0038","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuroimage.2010.01.005","article-title":"Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: exploring the influence of various parameters","volume":"50","author":"Franke","year":"2010","journal-title":"NeuroImage"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0039","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/001316448204200214","article-title":"Simplified determinations of statistical power, magnitude of effect and research sample sizes","volume":"42","author":"Friedman","year":"1982","journal-title":"Educ Psychol Meas"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0040","doi-asserted-by":"crossref","first-page":"e67346","DOI":"10.1371\/journal.pone.0067346","article-title":"BrainAGE in mild cognitive impaired patients: predicting the conversion to Alzheimer's disease","volume":"8","author":"Gaser","year":"2013","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0041","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0042","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2010.09.016","article-title":"Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism","volume":"41","author":"Glorioso","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0043","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","article-title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","volume":"80","author":"Gomperts","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0044","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hbm.24884","article-title":"Longitudinal brain atrophy distribution in advanced Parkinson\u2019s disease: what makes the difference in \u201ccognitive status\u201d converters?","volume":"41","author":"Gorges","year":"2020","journal-title":"Hum Brain Mapp"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0045","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1007\/s00213-018-5058-6","article-title":"Effects of Parkinson's disease and dopamine on digit span measures of working memory","volume":"235","author":"Grogan","year":"2018","journal-title":"Psychopharmacology"},{"issue":"Pt 4","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0046","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/brain\/aww008","article-title":"White matter hyperintensities and imaging patterns of brain ageing in the general population","volume":"139","author":"Habes","year":"2016","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0047","doi-asserted-by":"crossref","first-page":"e775","DOI":"10.1038\/tp.2016.39","article-title":"Advanced brain aging: relationship with epidemiologic and genetic risk factors, and overlap with Alzheimer disease atrophy patterns","volume":"6","author":"Habes","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2018.09.009","article-title":"Neural correlates of cognitive impairment in Parkinson's disease: a review of structural MRI findings","volume":"144","author":"Hall","year":"2019","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2019.10.016","article-title":"White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort","volume":"69","author":"Hanning","year":"2019","journal-title":"Parkinsonism & related disorders"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0050","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0051","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0000191154.78131.f6","article-title":"Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways","volume":"65","author":"Hilker","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0052","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afp223","article-title":"Ageing, neurodegeneration and Parkinson's disease","volume":"39","author":"Hindle","year":"2010","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0053","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mds.25748","article-title":"Predictors of cognitive impairment in an early stage Parkinson's disease cohort","volume":"29","author":"Hu","year":"2014","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0054","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0006-3223(91)90210-D","article-title":"Cerebral structure on MRI, Part I: Localization of age-related changes","volume":"29","author":"Jernigan","year":"1991","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0056","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/jnnp-2016-313838","article-title":"Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study","volume":"87","author":"Kalbe","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2013.03.008","article-title":"Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment","volume":"19","author":"Kandiah","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0058","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/s41593-019-0471-7","article-title":"Common brain disorders are associated with heritable patterns of apparent aging of the brain","volume":"22","author":"Kaufmann","year":"2019","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0059","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000341998","article-title":"Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis","volume":"11","author":"Kehagia","year":"2013","journal-title":"Neuro-degener Dis"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0060","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuroimage.2018.01.021","article-title":"Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease","volume":"190","author":"Kim","year":"2019","journal-title":"NeuroImage"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0061","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11910-019-1006-z","article-title":"Gray matter changes in Parkinson's and Alzheimer's disease and relation to cognition","volume":"19","author":"Krajcovicova","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00317","article-title":"A nonlinear simulation framework supports adjusting for age when analyzing BrainAGE","volume":"10","author":"Le","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0063","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11065-015-9307-8","article-title":"Do CSF biomarkers predict progression to cognitive impairment in Parkinson's disease patients? a systematic review","volume":"25","author":"Leaver","year":"2015","journal-title":"Neuropsychology Rev"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0064","doi-asserted-by":"crossref","DOI":"10.1002\/hbm.24588","article-title":"Investigating systematic bias in brain age estimation with application to post-traumatic stress disorders","volume":"40","author":"Liang","year":"2019","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0066","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/jon.12230","article-title":"White matter hyperintensities and mild cognitive impairment in Parkinson's disease","volume":"25","author":"Mak","year":"2015","journal-title":"J Neuroimaging"},{"issue":"Pt 10","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0067","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/brain\/awv211","article-title":"Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study","volume":"138","author":"Mak","year":"2015","journal-title":"Brain J Neurol"},{"issue":"21","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0068","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.211412398","article-title":"beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease","volume":"98","author":"Masliah","year":"2001","journal-title":"Proc Nat Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0069","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s00415-018-8800-4","article-title":"Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS)","volume":"265","author":"Monastero","year":"2018","journal-title":"J Neurol"},{"issue":"22","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0070","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0000000000000483","article-title":"Initial cognitive decline is associated with cortical thinning in early Parkinson disease","volume":"82","author":"Pereira","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0071","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Int Med"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2019.116450","article-title":"Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan","volume":"208","author":"Pomponio","year":"2020","journal-title":"NeuroImage"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0073","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.edurev.2010.12.001","article-title":"Eta squared and partial eta squared as measures of effect size in educational research","volume":"6","author":"Richardson","year":"2011","journal-title":"Educ Res Rev"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0074","doi-asserted-by":"crossref","first-page":"i151","DOI":"10.1093\/cercor\/bhm066","article-title":"Differential regulation of fronto-executive function by the monoamines and acetylcholine","volume":"17","author":"Robbins","year":"2007","journal-title":"Cerebral cortex (New York, N.Y. 1991)"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/acel.12312","article-title":"Parkinson's disease as a result of aging","volume":"14","author":"Rodriguez","year":"2015","journal-title":"Aging cell"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0076","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/cercor\/bhh032","article-title":"Thinning of the cerebral cortex in aging","volume":"14","author":"Salat","year":"2004","journal-title":"Cereb cortex (New York, N.Y. 1991)"},{"issue":"1-3","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0077","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0301-0511(00)00052-1","article-title":"Aging and measures of processing speed","volume":"54","author":"Salthouse","year":"2000","journal-title":"Biol Psychol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0078","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3758\/BF03210557","article-title":"Aging of attention: does the ability to divide decline?","volume":"23","author":"Salthouse","year":"1995","journal-title":"Mem Cogn"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0079","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study","volume":"16","author":"Schrag","year":"2017","journal-title":"Lancet Neurol"},{"issue":"14","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0080","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/mds.26051","article-title":"Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease","volume":"29","author":"Siepel","year":"2014","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0081","first-page":"1234","article-title":"Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies","volume":"90","author":"Smith","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0082","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.neuroimage.2019.06.017","article-title":"Estimation of brain age delta from brain imaging","volume":"200","author":"Smith","year":"2019","journal-title":"NeuroImage"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0083","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","article-title":"Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment","volume":"11","author":"Svenningsson","year":"2012","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0084","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mds.27204","article-title":"APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease","volume":"33","author":"Tropea","year":"2018","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0085","doi-asserted-by":"crossref","DOI":"10.1109\/TMI.2010.2046908","article-title":"N4ITK: improved N3 bias correction","volume":"29","author":"Tustison","year":"2010","journal-title":"IEEE Trans Med Imaging"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0086","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/mds.23664","article-title":"Parkinson's disease: the quintessential neuropsychiatric disorder","volume":"26","author":"Weintraub","year":"2011","journal-title":"Mov Disord"},{"issue":"Pt 1","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0087","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awr277","article-title":"Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease","volume":"135","author":"Weintraub","year":"2012","journal-title":"Brain J Neurol"},{"issue":"Pt 1","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0088","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awr277","article-title":"Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease","volume":"135","author":"Weintraub","year":"2012","journal-title":"Brain J Neurol"},{"issue":"Pt 7","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0089","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","article-title":"Evolution of cognitive dysfunction in an incident Parkinson's disease cohort","volume":"130","author":"Williams-Gray","year":"2007","journal-title":"Brain J Neurol"},{"issue":"7628","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature20411","article-title":"Ageing, neurodegeneration and brain rejuvenation","volume":"539","author":"Wyss-Coray","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0091","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41467-017-02416-0","article-title":"Network connectivity determines cortical thinning in early Parkinson's disease progression","volume":"9","author":"Yau","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurobiolaging.2021.08.020_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102196","article-title":"Topography of cortical thinning in the Lewy body diseases","volume":"26","author":"Ye","year":"2020","journal-title":"NeuroImage Clin"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.08.020_bib0093","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/jnnp-2012-304126","article-title":"Cortical thinning is associated with disease stages and dementia in Parkinson's disease","volume":"84","author":"Zarei","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021002748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021002748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:39:39Z","timestamp":1759318779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021002748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":93,"alternative-id":["S0197458021002748"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.08.020","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}